drugset / Trial / NCT00820144

Cholera Toxin B Subunit (CTB) Administered by Mucosal Way in Healthy Adult Volunteer

NCT00820144

Phase 1 Completed 40 enrolled Centre Hospitalier Universitaire de Nice
RandomizedFactorialOpen-labelBasic science

Summary

It is a biomedical research without direct individual benefit, exploring and comparing the mucosal immune response after oral, nasal and sublingual administration of B-subunit of non-toxic cholera toxin (CTB) in healthy adult volunteers.

Timeline

Start
2006-04
Primary completion
2006-04
Completion
2007-02

Drugs

EvaluationDrugModalityDoseRoute
Subject B-subunit of non-toxic cholera toxin Protein / enzyme biologic 0.25 mg Intranasal
Subject B-subunit of non-toxic cholera toxin Protein / enzyme biologic 0.5 mg Intranasal
Subject B-subunit of non-toxic cholera toxin Protein / enzyme biologic 1 mg Intranasal
Subject Shanchol Vaccine 1 mg Oral

Indications